NCT04188119 2025-12-08
IMpALA
The Christie NHS Foundation Trust
Phase 2 Withdrawn
Clinical Trials
15 trialsNCT02387203 2024-11-19
Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin
Mercy Medical Center
Phase 2 Active not recruiting
NCT04874935 2022-11-15
The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast Cancer
Tanta University
Phase 3 Completed
NCT03192059 2021-09-08
PRIMMO
University Hospital, Ghent
Phase 2 Completed
NCT04400136 2020-05-22
PPI Therapy Impact on GERD After Sleeve Gastrectomy
University of Roma La Sapienza
Phase EARLY_PHASE1 Unknown
NCT03794596 2019-07-22
IMpALA
The Christie NHS Foundation Trust
Phase 2 Withdrawn
NCT01279252 2019-01-25
CLEAR
King's College Hospital NHS Trust
Phase 2 Completed
NCT02150447 2018-04-04
The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding
National Cancer Center, Korea
Phase 3 Terminated
NCT02625259 2018-01-08
A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy Participants
Takeda
Phase 1 Completed
NCT02388581 2016-03-25
First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL
National Health Research Institutes, Taiwan
Phase 2 Unknown
NCT01216267 2013-01-16
Evaluation of Methods for the Determination of Chromogranin A in Routine Blood Samples
University of Western Ontario, Canada
Phase NA Completed
NCT00204373 2012-10-30
Treatment of Zollinger-Ellison Syndrome With Prevacid
University of Alabama at Birmingham
Phase 4 Completed
NCT00928161 2012-09-07
Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy
M.D. Anderson Cancer Center
Phase NA Withdrawn
NCT00942175 2012-02-03
A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.
Takeda
Phase 1 Completed
NCT00352261 2009-03-26
An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients
AstraZeneca
Phase 4 Completed